Shuang Cai

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Kansas, Hylapharm, LLC. Active years: 2012-2025.

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 85.7

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12295970 - Imidazoquinoline compounds and prodrugs thereof (2025-05-13),

2. 11458163 - Platinum(IV) conjugates and methods of use (2022-10-04),

3. 10857199 - Compounds and methods for increasing hair growth (2020-12-08),

4. 10350263 - Compounds and methods for increasing hair growth (2019-07-16),

5. 10213479 - Compounds and methods for increasing hair growth (2019-02-26),

6. 8802235 - Drug and imaging agent delivery compositions and methods (2014-08-12),

7. 8088412 - Intralymphatic chemotherapy drug carriers (2012-01-03),

Title: Shuang Cai: Innovator in Pharmaceutical Compounds

Introduction

Shuang Cai is a prominent inventor based in Lawrence, KS (US), known for her significant contributions to the field of pharmaceutical compounds. With a total of 7 patents, she has made remarkable strides in developing innovative treatments for various medical conditions.

Latest Patents

Among her latest patents, Shuang Cai has developed imidazoquinoline compounds and prodrugs thereof. This technology focuses on TLR7 and TLR8 agonist compounds, compositions, and methods for treating cancers and serving as vaccine adjuvants. Additionally, she has worked on platinum(IV) conjugates and methods of use, providing platinum(IV) compounds of specific formulas and their pharmaceutically acceptable salts, along with compositions and methods for their application.

Career Highlights

Shuang Cai has had a distinguished career, working with notable institutions such as the University of Kansas and Hylapharm, LLC. Her work has been instrumental in advancing the understanding and application of pharmaceutical compounds in medical treatments.

Collaborations

Throughout her career, Shuang has collaborated with esteemed colleagues, including Daniel J Aires and Kenneth Ryan Moulder. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Shuang Cai's contributions to the field of pharmaceutical innovations highlight her role as a leading inventor. Her work continues to impact the medical community positively, paving the way for new treatments and therapies.